Partnering for Formulation Development

Child Formulation

The Pediatric Formulation Gap

Pharma's Almanac

TPDs

Low Dose, High Impact: Microdosing, Content Uniformity, and Precision Control in TPDs

David O’Connell

PCI Pharma Services

Partner Selection

How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?

Pharma's Almanac

ADC Formulation

Controlling Complexity in ADC Formulation Development

Eunbi Iris Cho, Ph.D.

Samsung Biologics

Combination Products

Collaboration is Key to Successful Injectable Drug–Device Combination Product Development

Cynthia A. Challener, Ph.D.

Pharma's Almanac

High-Concentration

High-Concentration Biologics Are Redefining Subcutaneous Delivery

Pharma's Almanac

LAI Formulation

The Formulation Science Behind Extended Drug Release

Pharma's Almanac

Drug–Device

Designing Formulations Around Devices Rather Than Vice Versa

Pharma's Almanac

CRO Partnerships

Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control

Brian Healey

IQVIA

Outsourcing

The Hidden Operational Costs of Multi-Vendor Outsourcing Models

Pharma's Almanac